Baseline inflammatory markers do not modulate the lipid response to weight loss

Metabolism: Clinical and Experimental

Volumn 57, Issue 5, 2008, Pages 598-604

  St Onge, Marie Pierre ^a,b,c   Desmond, Renee ^b,c   Hunter, Gary ^a,c   Gower, Barbara ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; RISK FACTOR; WEIGHT REDUCTION;

ABDOMINAL FAT; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; FEMALE; HUMANS; INTERLEUKIN-6; LIPIDS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 42949178433     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.12.001     Document Type: Article

References (23)

1. Libby P., and Ridker P.M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116 Suppl 6A (2004) 9S-16S
2. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
3. Ridker P.M., Rifai N., Cook N.R., Bradwin G., and Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
4. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
5. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
6. Hanley A.J., Festa A., D'Agostino Jr. R.B., et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53 (2004) 1773-1781
7. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
8. Desroches S., Archer W.R., Paradis M.E., et al. Baseline plasma C-reactive protein concentrations influence lipid and lipoprotein responses to low-fat and high monounsaturated fatty acid diets in healthy men. J Nutr 136 (2006) 1005-1011
9. Hilpert K.F., Kris-Etherton P.M., and West S.G. Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J Nutr 135 (2005) 1075-1079
10. Zhao G., Etherton T.D., Martin K.R., West S.G., Gillies P.J., and Kris-Etherton P.M. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 134 (2004) 2991-2997
11. Erlinger T.P., Miller III E.R., Charleston J., and Appel L.J. Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: results from the DASH-sodium trial. Circulation 108 (2003) 150-154
12. Lara-Castro C., Weinsier R.L., Hunter G.R., and Desmond R. Visceral adipose tissue in women: longitudinal study of the effects of fat gain, time, and race. Obes Res 10 (2002) 868-874
13. Bergman R.N., Phillips L.S., and Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68 (1981) 1456-1467
14. Pacini G., and Bergman R.N. MINROD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23 (1986) 113-122
15. Yang Y.J., Youn J.H., and Bergman R.N. Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 253 (1987) E595-E602
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
18. Heliovaara M.K., Teppo A.M., Karonen S.L., Tuominen J.A., and Ebeling P. Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects. Diabetes Obes Metab 7 (2005) 729-736
19. Piche M.E., Lemieux S., Weisnagel S.J., Corneau L., Nadeau A., and Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 96 (2005) 92-97
20. Bluher M., Fasshauer M., Tonjes A., Kratzsch J., Schon M.R., and Paschke R. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 113 (2005) 534-537
21. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46 (2005) 464-469
22. Fenster C.P., Darley-Usmar V.M., Landar A.L., et al. Weight loss and race modulate nitric oxide metabolism in overweight women. Free Radic Biol Med 37 (2004) 695-702
23. Oda E., Abe M., Kato K., Watanabe K., Veeraveedu P.T., and Aizawa Y. Gender differences in correlations among cardiovascular risk factors. Gend Med 3 (2006) 196-205